Evidence map›Paper›PMID 33854349›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2021

Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes.

Mateusz Mieczkowski, Beata Mrozikiewicz-Rakowska, Tomasz Siwko, Magdalena Bujalska-Zadrozny, Anna de Corde-Skurska, Renata Wolinska, Emilia Gasinska, Tomasz Grzela, Piotr Foltynski, Michal Kowara and 2 more

Open access · goldAbstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Mateusz MieczkowskiDepartment of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0002-1489-3407
Beata Mrozikiewicz-RakowskaDepartment of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0002-1160-9204
Tomasz SiwkoDepartment of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Magdalena Bujalska-ZadroznyDepartment of Pharmacodynamics, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0002-4270-6373
Anna de Corde-SkurskaDepartment of Pharmacodynamics, Medical University of Warsaw, Warsaw, Poland.
Renata WolinskaDepartment of Pharmacodynamics, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0002-8472-6508
Emilia GasinskaDepartment of Pharmacodynamics, Medical University of Warsaw, Warsaw, Poland.
Tomasz GrzelaDepartment of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-8519-4868
Piotr FoltynskiNalecz Institute of Biocybernetics and Biomedical Engineering Polish Academy of Sciences, Warsaw, Poland.ORCID 0000-0002-6678-1968
Michal KowaraDepartment of Cardiology, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0003-3689-4192
Zofia MieczkowskaDepartment of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Leszek CzupryniakDepartment of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0003-2396-8885
Medical University of Warsaw · PLInstitute of Biocybernetics and Biomedical Engineering · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOptimal glycemic control is crucial for proper wound healing in patients with diabetes. However, it is not clear whether other antidiabetic drugs support wound healing in mechanisms different from the normalization of blood glucose control. We assessed the effect of insulin and metformin administration on the wound healing process in rats with streptozotocin-induced diabetes.

methodsThe study was conducted on 200 male Wistar rats with streptozotocin-induced diabetes. In the last phase of the study, 45 rats, with the most stable glucose levels in the range of 350-500 mg/dL, were divided into three groups: group I received human non-protamine insulin subcutaneously (5 IU/kg body mass) once a day, group II received metformin intragastrically (500 mg/kg b.m.), and group III (control) was given saline subcutaneously. After 14 days of antidiabetic treatment, a 2 cm × 2 cm thin layer of skin was cut from each rat's dorsum and a 4 cm disk with a hole in its center was sewn in to stabilize the skin and standardize the healing process. The wound healing process was followed up for 9 days, with assessment every 3 days. Biopsy samples were subjected to hematoxylin and eosin staining and immunohistochemical assays.

resultsAnalysis of variance revealed significant influence of treatment type (insulin, control, or metformin) on the relative change in wound surface area. The wound healing process in rats treated with insulin was more effective than in the metformin and control groups. Wound tissue samples taken from the insulin-treated animals presented significantly lower levels of inflammatory infiltration. Immunohistochemical assessment showed the greatest density of centers of proliferation Ki-67 in insulin-treated animals.

conclusionThese results suggest that an insulin-based treatment is more beneficial than metformin, in terms of accelerating the wound healing process in an animal model of streptozocin-induced diabetes.

Indexed as

animal modeldiabetes mellitusneuropathyulceration

Identifiers

PMID33854349
PMCPMC8039538
OpenAlexW3150969428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.